Abstract:Objective To explore hypermethylation of RARβ2, GSTP1 and DAPK gene in prostate cancer tissues, and to explore its correlation with clinicopathological features of prostate cancer and its diagnostic value. Methods Hypermethylation of RARe2, GSTP1 and DAPK gene was detected by nested methylation-specific PCR (NMSP) in 57 prostate cancer (PCa) tissues and 35 benign prostate hyperplasia (BPH) tissues. The correlation between hypermethylation and clinicopathological features of prostate cancer and its diagnostic value were analyzed. Results The hypermethylation frequencies of RARβ2, GSTP1 and DAPK gene in PCa were significantly higher than those in BPH (RARβ2: 52.6% vs. 0% GSTP1: 61.4% vs. 2.9%;DAPK: 43.9% vs. 8.6%;all P<0.01). The methylation rate of RARβ2 gene was directly correlated with distinct Gleason scores and clinical stage (4～7 score vs. 8～10 score: 34.8% vs. 64.7%;stage B, C vs. stage D: 37.0% vs. 66.7%;x2=4.927 and 5.004, P=0.026 and 0.025). The methylation rate of GSTP1 gene was significantly different in patients with different Gleason scores (4～7 score vs. 8～10 score: 43.5% vs. 73.5%;x2 =11.530, P=0.001), but had no difference in patients with distinct clinical stage (stage B, C vs. stage D: 51.9% vs. 70.0%;x2=1.975, P=0.16) . There was no difference in DAPK gene methylation rate among patients with different Gleason scores and distinct clinical stage (4 ～7 score vs. 8～10 score: 39.1% vs. 50.0%;stage B, C vs. stage D: 33.3% vs. 53.3%;x2= 1.290 and 2.309, both P～0.05). GSTP1 gene showed the highest sensitivity of 61.4% (35/57)with specificity of 97.1%(34/35), while RARβ2 gene had the highest specificity of 100% (35/35) with the sensitivity of 52.6% (30/57). The sensitivity and specificity of DAPK gene were 43.9% and 91.4% (25/57 and 32/35), respeetively. When the hypermethylation of RARβ2, GSTP1 and DAPK gene were detected together, the diagnostic sensitivity was increased, but the specificity was decreased. Conclusions The aberrant methylation of RARβ2, GSTP1 and DAPK gene is correlated with tumorigenesis and progression of prostate cancer, which may be used as an effective diagnostic marker for prostate cancer.

Hypermethylation of the SPARC Promoter and Its Prognostic Value for Prostate Cancer.

Detection of aberrant methylation of RARβ2, GSTP1 and DAPK gene in prostate cancer and its clinical significance

Hypermethylation of GSTP1 and DAPK gene in prostate cancer

Aberrant methylation of the SPARC gene promoter and its clinical implication in gastric cancer

Aberrant promoter methylation of SPARC in ovarian cancer

Prognostic Role of Secreted Protein Acidic and Rich in Cysteine in Patients with Solid Tumors

Correlation Between Secreted Protein Acidic and Rich in Cysteine Protein Expression and the Prognosis of Postoperative Patients Exhibiting Esophageal Squamous Cell Carcinoma

Aberrant Methylation Status of SPG20 Promoter in Hepatocellular Carcinoma: A Potential Tumor Metastasis Biomarker.

Prognostic role of SPARC expression in gastric cancer: a meta-analysis.

Systematic Review/meta-analysis Prognostic Role of Sparc Expression in Gastric Cancer: a Meta-analysis

Research Progress on SPARC in Pathogenesis of Gastric Cancer

SPARC Promotes the Proliferation and Metastasis of Oral Squamous Cell Carcinoma by PI3K/AKT/PDGFB/PDGFRβ Axis

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer.

Sparcl1 Exhibits Different Expression Pattern Between Left- And Right-Sided Colon Cancer And It Was Down-Regulated Via Dna Methylation

PITX2 Methylation: a Novel and Effective Biomarker for Monitoring Biochemical Recurrence Risk of Prostate Cancer

Clinical Significance of Methylation of E-cadherin and P14arf Gene Promoters in Skin Squamous Cell Carcinoma Tissues.

Sparc Expression in Primary Tumor and Metastatic Lymph Node of Resected Pancreatic Cancer Patients and Its Impact on Prognosis.

SPARC Overexpression Promotes Liver Cancer Cell Proliferation and Tumor Growth

Low Levels of SPARC are Associated with Tumor Progression and Poor Prognosis in Human Endometrial Carcinoma

Epigenetic modification‐dependent androgen receptor occupancy facilitates the ectopic TSPY1 expression in prostate cancer cells

SPARC is a Novel Prognostic Biomarker for Ovarian Cancer and Associated with Immune Signatures and Drug Response